Omega Fund Management’s Immunic IMUX Stock Holding History

Omega Fund Management’s Portfolio IMUX Stock Details IMUX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-178,816	Closed	-$1.25M	–	13
2025 Q2	$1.25M	Hold	178,816	–	–	0.81%	12
2025 Q1	$1.95M	Hold	178,816	–	–	1.15%	11
2024 Q4	$1.79M	Hold	178,816	–	–	1.16%	9
2024 Q3	$2.95M	Hold	178,816	–	–	1.84%	9
2024 Q2	$1.98M	Hold	178,816	–	–	1.47%	9
2024 Q1	$2.36M	Hold	178,816	–	–	1.52%	8
2023 Q4	$2.68M	Hold	178,816	–	–	2.17%	11
2023 Q3	$2.63M	Hold	178,816	–	–	2.41%	8
2023 Q2	$4.49M	Hold	178,816	–	–	2.51%	10
2023 Q1	$2.66M	Hold	178,816	–	–	1.74%	11
2022 Q4	$2.5M	Hold	178,816	–	–	0.84%	12
2022 Q3	$5.65M	Hold	178,816	–	–	2.07%	10
2022 Q2	$6.21M	Hold	178,816	–	–	1.98%	11
2022 Q1	$20.2M	Hold	178,816	–	–	4.14%	7
2021 Q4	$17.1M	Hold	178,816	–	–	2.42%	9
2021 Q3	$15.8M	Hold	178,816	–	–	1.78%	11
2021 Q2	$21.9M	Hold	178,816	–	–	2.48%	8
2021 Q1	$28.5M	Hold	178,816	–	–	2.7%	9
2020 Q4	$27.3M	Hold	178,816	–	–	4.1%	7
2020 Q3	$33.2M	Buy	178,816 +41,667	+30%	+$6.82M	8.98%	4
2020 Q2	$16.6M	Hold	137,149	–	–	4.55%	5
2020 Q1	$8.3M	Hold	137,149	–	–	3.43%	6
2019 Q4	$13.3M	Hold	137,149	–	–	4.23%	5
2019 Q3	$13.7M	Hold	137,149	–	–	4.23%	5
2019 Q2	$15.7M	Buy	+137,149	New	+$18M	4.01%	5

Other funds holding IMUX

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Omega Fund Management's IMUX Position: Q3 2025 in Review

Omega Fund Management sold out of Immunic (IMUX) in Q3 2025, closing a stake of 178,816 shares — an estimated $1.25M sold.

Omega Fund Management first reported a position in IMUX in Q2 2019 and held it in 25 quarters. The position peaked at $33.2M in Q3 2020. 59 funds tracked by Wall St. Rank hold IMUX as of Q3 2025.

Omega Fund Management reported no remaining Immunic position as of Q3 2025 after selling out during the quarter.
Omega Fund Management sold 178,816 Immunic shares in Q3 2025, an estimated $1.25M.
Omega Fund Management first reported a position in Immunic in Q2 2019 and held it in 25 quarters.
Omega Fund Management's Immunic position peaked at $33.2M in Q3 2020.
59 funds tracked by Wall St. Rank held Immunic as of Q3 2025.

Based on Omega Fund Management's 13F filing for Q3 2025, filed 14 Nov 2025.